7 Symptoms of Paget’s Disease of the Breast Often Mistaken for Skin Conditions

Paget’s disease of the breast is a rare form of breast cancer that affects the nipple and often the areola, the darker skin surrounding the nipple. What makes it easy to miss is that its early signs can look like common skin problems, such as eczema, dermatitis, irritation, or a stubborn rash. A person may notice itching, redness, flaking, crusting, or nipple discharge and assume it is only a surface-level skin issue. That misunderstanding can delay medical evaluation, especially when symptoms come and go at first.

Knowing the symptoms of Paget’s disease of the breast matters because this condition is often linked with underlying breast cancer in the same breast. Unlike a simple rash, these changes usually affect one nipple and may continue to worsen over time. Paying attention to unusual nipple or areola changes can help you seek care earlier and receive the right tests. In this article, we look at seven symptoms of Paget’s disease of the breast that are often mistaken for skin conditions.

Defining Paget’s Disease of the Breast

Paget’s disease of the breast is a rare and distinct form of breast cancer that specifically targets the skin of the nipple and the surrounding dark circle of skin known as the areola. This condition is highly significant because it rarely occurs in isolation; instead, it typically serves as an external warning sign that alerts clinicians to an underlying malignancy situated deeper within the breast tissue.

Pathologically, the condition is defined by the presence of large, abnormal cancer cells called Paget cells within the epidermis, which is the outermost layer of the skin. Under a microscope, these cells feature a distinct pale cytoplasm and prominent, irregular nuclei. They can be found scattered individually or grouped in small clusters throughout the skin layers.

Because Paget cells are adenocarcinomas—meaning they originate from glandular tissue—medical science long sought to explain how they arrive on the surface of the skin. The most widely accepted explanation is the migration theory. This theory states that the cancer begins inside the milk ducts of the breast and the malignant cells physically travel upward through the fluid-carrying channels until they break through the skin surface of the nipple, triggering visible inflammatory changes.

In roughly 90% to 97% of all documented cases, individuals diagnosed with paget’s disease of the nipple harbor an underlying cancer. This hidden malignancy is usually either ductal carcinoma in situ (DCIS), which is a non-invasive cancer confined entirely inside the milk ducts, or invasive ductal carcinoma, where the cancer cells have broken through the duct walls to invade the surrounding fat and supportive tissue.

In approximately half of these patients, a physical, palpable lump or dense mass can be felt during a physical breast exam, which usually indicates that the underlying cancer has become invasive. When no lump can be detected by touch, the hidden cancer is more likely to be non-invasive DCIS. Because of this powerful, direct connection, finding these specialized cells on the skin surface requires an immediate and exhaustive medical investigation of the deeper breast anatomy to trace the true extent of the disease.

What Causes the Condition and Who Is at Risk?

The underlying causes that trigger paget’s disease breast malignancies mirror the complex genetic and environmental factors that drive traditional breast cancers. Because it is an extension of ductal carcinoma, any biological element that damages the cellular matrix of the milk ducts can inadvertently cause this condition to manifest.

The Impact of Age and Lifespan Exposures

The most prominent, non-modifiable risk factor for developing pagets disease breast tumors is advancing age. The vast majority of cases are diagnosed in individuals over the age of 50, with the median age of diagnosis hovering around 62 years old. The disease is exceptionally rare in young adults under the age of 30. This strong chronological link is driven by the natural, cumulative cellular damage that occurs over a lifetime, alongside decades of fluctuating hormonal exposures that can gradually push vulnerable ductal cells toward a malignant state.

Genetic Predispositions and Family History

A personal or family history of oncological disease serves as a major risk indicator. A person who has successfully battled cancer in one breast carries a statistically higher risk of developing a new, separate malignancy in the opposite breast or a different quadrant of the same breast.

Furthermore, having a first-degree biological relative—such as a mother, sister, or daughter—who has been diagnosed with breast cancer can double an individual’s baseline risk. This familial danger climbs even higher if that relative was diagnosed at an early age.

This strong familial connection is frequently linked to inherited genetic mutations passed down through generations. Inherited mutations within the BRCA1 and BRCA2 tumor-suppressor genes drastically impair the body’s ability to repair damaged DNA, exponentially increasing the lifetime risk of developing breast, ovarian, and pancreatic cancers.

Other inherited genetic variants in genes such as PALB2, CHEK2, and ATM also undermine cellular stability and elevate risk. Beyond genetics, traditional breast cancer risk factors—including possessing high breast tissue density on a mammogram, starting menstruation early in life (before age 12), entering menopause late (after age 55), or experiencing a first full-term pregnancy after the age of 30—all increase a person’s susceptibility to paget’s disease of the breast.

The 7 Key Symptoms of Paget’s Disease of the Breast

Because paget’s disease of the breast primarily mirrors common, benign dermatological issues, its warning signs are easily misidentified. The condition occurs almost exclusively in one breast, causing progressive, localized changes across the nipple-areola complex.

The seven key symptoms include:

• Localized itching, tingling, or burning
• Visible redness and raw inflammation
• Flaky, scaly, or thickened skin texture
• Crusting, oozing, or weeping fluid from open sores
• Recent nipple flattening or structural inversion
• Spontaneous ductal nipple discharge (bloody or straw-colored)
• A distinct palpable lump deeper within the breast tissue

Skin-Related Symptoms on the Nipple and Areola

The earliest presentation of paget’s disease breast malignancies typically mimics inflammatory skin conditions like eczema, psoriasis, or contact dermatitis. This visual overlap is a primary cause of delayed diagnosis.

Localized Itching, Tingling, or Burning

One of the earliest and most persistent sensory symptoms is a localized, chronic itch or tingling sensation deep within the nipple skin. Unlike standard dry skin or an allergic reaction, this discomfort does not resolve over time. Patients often report an intense, bothersome “pins-and-needles” feeling or a distinct burning pain. A major clinical red flag is that this sensory irritation fails to respond to over-the-counter hydrocortisone creams or daily moisturizers.

Redness, Inflammation, and Flaky Skin

The affected skin becomes noticeably red, inflamed, and irritated, presenting as a well-defined patch. As malignant cells infiltrate the epidermis, they disrupt normal cellular turnover. This causes the surface layer to become flaky and rough, with small pieces of skin peeling away. In advanced stages, the skin can feel abnormally thick, leathery, and rough to the touch, losing all of its natural smoothness.

Crusting, Oozing, and Open Ulceration

As the disease progresses, the integrity of the skin completely breaks down, resulting in surface erosions or raw, open ulcerations. This damaged tissue may weep a clear, yellowish fluid or a small amount of blood. When this fluid dries, it creates a persistent crust or scab across the surface. This is not fluid coming out of the milk ducts, but rather fluid leaking directly from the damaged skin surface itself. A non-healing, crusted sore on the nipple is a classic indicator of this underlying disease.

Structural and Discharge-Related Symptoms

When the underlying cancer grows or creates structural pull within the tissue, symptoms expand beyond the skin surface to involve the underlying ductal system and breast tissue architecture.

Nipple Flattening or Inversion

A previously normal, outward-pointing nipple may begin to lose its shape, becoming flat against the areola or pulling entirely inward. This structural retraction occurs because the underlying cancer cells trigger the formation of tight, scar-like fibrous tissue within the milk ducts. This fibrous tissue acts as a tether, pulling the nipple backward into the breast. While some individuals have naturally inverted nipples from birth, a new or asymmetrical shift in nipple position requires an immediate medical evaluation.

Spontaneous Ductal Nipple Discharge

Distinct from surface oozing, this symptom involves fluid traveling through the lactiferous ducts and escaping from the nipple openings. This discharge often occurs spontaneously without any squeezing or pressure, and can be clear, straw-colored, or distinctly bloody. A persistent, single-duct bloody discharge is a classic sign of an underlying ductal carcinoma.

A Palpable Breast Lump or Mass

In roughly half of all diagnosed cases of pagets disease breast malignancies, a distinct, firm mass can be felt during a physical evaluation. This lump represents the primary tumor site—typically an invasive ductal carcinoma. The mass may be situated directly underneath the nipple-areola complex or hidden deeper within an outer quadrant of the breast. Finding a palpable mass alongside surface skin changes often points to a more advanced disease stage, making prompt diagnostic imaging via diagnostic mammograms and targeted ultrasounds vital to mapping the hidden tumor.

Deep-Dive Diagnostic Protocols: Tracing the Malignant Blueprint

Confirming a diagnosis of paget’s disease of the breast requires an exhaustive, multi-phase clinical approach. Because this malignancy presents outwardly on the skin while typically hiding a separate tumor deep within the breast architecture, doctors must rely on an advanced combination of manual exams, high-resolution imaging, and cellular pathology. The diagnostic journey must not stop at the surface; it is designed to map the entire malignant blueprint of the breast.

The process begins with a detailed clinical breast examination. A breast specialist or surgical oncologist manually evaluates the tissue, inspecting the symmetry, contours, and skin texture of both breasts. Because underlying invasive breast cancers have a high affinity for migrating through the lymphatic network, the clinician will carefully palpate the axillary lymph nodes located under the armpit, as well as the supraclavicular nodes near the collarbone. Any physical swelling, firmness, or lack of mobility in these nodes serves as an immediate warning sign that an underlying cancer may have begun to spread.

[Visual Skin Changes] ──► [Deep Tissue Mapping] ──► [Cellular Confirmation]
  - Nipple redness          - Diagnostic Mammogram     - Punch or Wedge Biopsy
  - Scaling/Crusting        - Breast Ultrasound        - Pathological Review
  - Structural inversion    - Contrast Breast MRI      - Immunohistochemistry

To locate the hidden malignancy that drives the surface changes, doctors utilize a targeted tier of diagnostic imaging protocols:

Diagnostic Mammogram: This is the foundational baseline imaging standard for any suspected breast cancer. Unlike a routine screening mammogram, a diagnostic mammogram takes multiple highly focused, magnified views of the nipple-areolar complex and the tissue directly behind it. While the visual skin changes of Paget’s disease may not show up on an X-ray, the mammogram is essential for detecting clusters of pleomorphic microcalcifications—tiny calcium deposits that often signal the presence of ductal carcinoma in situ (DCIS)—or architectural distortions that indicate a deeper, solid mass.

Targeted Breast Ultrasound: Used in direct conjunction with a mammogram, ultrasound imaging utilizes high-frequency sound waves to evaluate dense breast tissue. It is an exceptional tool for distinguishing between fluid-filled benign cysts and solid, malignant masses. Ultrasound is particularly valuable for mapping small, solid tumors tucked directly beneath or adjacent to the nipple-areola complex, which can sometimes be obscured on a standard mammogram due to the dense muscular structure of the nipple.

Contrast-Enhanced Breast MRI: In highly complex scenarios, or when standard mammography and ultrasound yield inconclusive results, a breast Magnetic Resonance Imaging (MRI) scan is ordered. By utilizing an intravenous contrast dye (gadolinium), an MRI tracks blood flow patterns throughout the breast. Malignant tumors rapidly recruit new blood vessels, a process known as angiogenesis, which causes the contrast dye to “light up” intensely on the scan. A breast MRI provides a high-definition, cross-sectional map of both breasts, allowing oncologists to see the exact structural boundaries of the disease and rule out multifocal or multicentric tumors that may be hidden deep within other quadrants of the breast.

While advanced imaging provides an excellent structural map, the definitive diagnosis of paget’s disease breast malignancies requires a physical tissue biopsy analyzed under a microscope by a board-certified pathologist. To obtain a valid sample, a surgeon will perform a brief outpatient procedure using local anesthesia.

Depending on the physical presentation of the skin, they may use a punch biopsy, which utilizes a small, circular coring tool to remove a full-thickness cylinder of skin from the most affected area of the nipple. If the tissue is highly eroded, a shave biopsy may be used to carefully harvest the upper layers of altered skin, or a surgical wedge biopsy may be deployed to remove a small, V-shaped piece of the nipple structure.

The diagnosis is officially confirmed when the pathologist identifies pathognomonic Paget cells scattered throughout the epithelial skin layer. To ensure no detail is missed, the pathologist will perform immunohistochemical (IHC) staining on the tissue sample. Paget cells typically test positive for specific cellular markers, such as cytokeratin 7 (CK7) and the HER2 oncoprotein, which helps distinguish them from other rare skin disorders or melanoma cells.

Paget’s Disease vs. Eczema: The Vital Clinical Distinctions

Misidentifying a rare malignant tumor as a common, benign case of areolar eczema (atopic dermatitis) or contact dermatitis is one of the most significant clinical risks in breast oncology. Because both conditions present as a red, scaly, and intensely itchy rash across the delicate skin of the nipple and areola, patients and primary care providers frequently mistake the early stages of cancer for a simple dermatological flare-up.

This visual overlap can lead to a dangerous delay in diagnosis, giving an underlying, hidden breast cancer months to grow and progress into an advanced stage. However, by looking closely at how the tissue behaves over time, clinicians can spot the vital differences between these two conditions.

The most telling clinical indicator is how the affected skin responds to conventional dermatological therapies. Eczema is an inflammatory skin condition driven by immune hyperreactivity or external irritants; therefore, it typically shows rapid improvement when treated with prescription topical steroid creams, barrier repairs, and rich emollients.

Conversely, paget’s disease of the nipple is a malignant process driven by a steady proliferation of cancer cells. It is completely unresponsive to topical steroids, and while a steroid cream might temporarily lessen superficial inflammation, the underlying disease will continue to steadily worsen, crust, and erode the tissue despite treatment.

Another definitive differentiator is anatomical laterality. Eczema is a systemic skin condition that typically manifests symmetrically, meaning it commonly appears on both breasts simultaneously. Conversely, Paget’s disease is an isolated, oncological event rooted in the ductal system of a single breast; as a result, it presents almost exclusively on one side of the body.

Furthermore, as malignant Paget cells continue to infiltrate the epidermis, they break down the structural integrity of the skin in ways that eczema never does. Over time, the cancer creates deep, non-healing ulcerations or raw, open sores that fail to close.

As the cancer cells accumulate within the subareolar milk ducts, they create a dense pull that can cause the nipple to flatten out or permanently turn inward (nipple inversion). Eczema can cause the skin to flake, peel, or weep clear fluid due to scratching, but it will never alter the underlying muscular structure or position of the nipple.

Finally, the specific nature of the pain and sensory presentation provides important diagnostic clues. While areolar eczema is characterized by a sharp, superficial itch that prompts a strong urge to scratch, the sensation driving a malignant tumor is felt deeper within the tissue.

Patients with Paget’s disease often report a persistent, localized burning sensation or an intense, chronic tingling that feels like “pins and needles” under the skin. Any unilateral nipple rash that does not completely resolve within a few weeks of standard dermatological treatment must be biopsied immediately to rule out malignancy.

The Biological Link to Hidden Breast Malignancies

The connection between the external skin changes of pagets disease breast lesions and a hidden internal tumor is exceptionally strong and serves as the central factor that dictates a patient’s treatment and prognosis. In more than 90% of all documented cases, the red, crusty skin on the nipple is not a primary skin cancer, but rather an outward warning sign of an underlying breast cancer situated deeper within the breast anatomy.

According to the widely accepted migration theory, these specialized malignant surface cells do not originate on the skin of the nipple. Instead, they begin as a primary tumor inside the deeper lining of the milk ducts. Over months or years, these cancer cells break away from the main tumor site and travel upward through the lactiferous ductal system, using the fluid channels as a highway to reach the surface.

Once they arrive at the nipple openings, they infiltrate the epidermis of the nipple and areola, proliferating and causing the classic inflammatory symptoms that patients notice.

[Deep Milk Ducts] ──► [Upward Migration] ──► [Epidermal Infiltration]
  - Primary Tumor Forms    - Cells travel through     - Cells accumulate in skin
  - DCIS or Invasive IDC     lactiferous ducts        - Triggers rash/crusting

The specific type and stage of this hidden underlying tumor are the primary factors that dictate a patient’s long-term outlook:

Non-Invasive Underlying Cancer (DCIS)

If advanced imaging, physical exams, and pathology reveal that the disease has not formed a mass and is confined entirely within the ductal system, the prognosis is generally excellent. In this scenario, the hidden cancer is ductal carcinoma in situ (DCIS).

Because DCIS is a non-invasive form of cancer, the abnormal cells are completely contained inside the protective walls of the milk ducts and have not gained the biological ability to invade the surrounding fat tissue or travel to distant organs. When Paget’s disease is driven purely by DCIS, the long-term survival rates are exceptionally high, and the treatment focuses primarily on local control and preventing future recurrence.

Invasive Underlying Cancer (Invasive Ductal Carcinoma)

If a distinct, firm lump can be felt during a physical evaluation or is mapped on an ultrasound, there is a greater than 90% chance that the hidden cancer has evolved into an invasive ductal carcinoma (IDC). This means the malignant cells have broken through the protective walls of the milk ducts and invaded the surrounding fatty and supportive stroma of the breast.

Once a cancer becomes invasive, it gains access to blood vessels and lymphatic channels, creating a pathway to travel to other parts of the body. When an invasive component is present, the overall prognosis depends on the specific stage of that deeper tumor, including its physical size, whether malignant cells have spread to the underarm lymph nodes, and the tumor’s genetic receptor status. This requires a more aggressive, multi-disciplinary approach to treatment.

Comprehensive Treatment Framework: From Surgery to Systemic Care

The treatment plan for paget’s disease of the breast is highly personalized. It is designed by a multidisciplinary team of breast surgeons, medical oncologists, and radiation oncologists to remove all cancerous cells from the breast while minimizing the risk of a local or systemic recurrence.

Surgical Intervention Options

Surgery is the primary treatment for Paget’s disease, and the exact surgical approach is chosen based on the size and location of any underlying cancer found during imaging and biopsy.

Breast-Conserving Surgery (Lumpectomy): If diagnostic imaging and pathology confirm that the cancer is localized and has not formed a widespread deep tumor, patients may be candidates for breast-conserving surgery. The surgeon performs a wide local excision to remove the entire nipple-areola complex along with a cone-shaped wedge of the underlying milk ducts, ensuring that the outer edges of the removed tissue are completely clear of cancer cells (negative margins). To ensure long-term safety, this conservative option is almost always followed by a full course of external beam radiation therapy to the remaining breast tissue to destroy any stray, microscopic cancer cells and lower the risk of recurrence.

Total Mastectomy: If the underlying cancer has become invasive, spans multiple areas of the breast (multicentric disease), or if the tumor is large relative to the size of the breast, a total mastectomy is recommended. This involves the complete surgical removal of the entire breast tissue, including the skin, fat, and the nipple-areola complex. Depending on the patient’s preferences and the stage of the cancer, breast reconstruction surgery can often be performed at the same time as the mastectomy or delayed until a later date.

Lymph Node Evaluation

When an invasive cancer component is identified or when a total mastectomy is performed, evaluating the lymph nodes under the arm is a vital step in checking for localized spread. Surgeons typically perform a Sentinel Lymph Node Biopsy (SLNB).

During this procedure, a small amount of blue dye or a radioactive tracer is injected into the breast near the tumor. The dye travels naturally through the lymphatic fluid to the very first lymph node (the “sentinel” node) that drains the breast.

The surgeon removes only this specific node and sends it to a pathologist for immediate review. If the sentinel node is completely clear of cancer, no further lymph nodes need to be removed, which significantly lowers the patient’s risk of developing chronic arm swelling (lymphedema).

[Injected Dye/Tracer] ──► [Maps Lymph Pathway] ──► [Biopsy Sentinel Node Only]
  - Near tumor site         - Follows natural fluid     - If negative: stop surgery
  - Outpatient setting        drainage to armpit        - If positive: check more nodes

Adjuvant Systemic Therapies

If an invasive cancer component is identified during pathological review, systemic treatments are introduced to target and eliminate any wandering cancer cells throughout the body:

Targeted Chemotherapy: Administered in cycles, these potent medications travel through the bloodstream to systematically disrupt and kill rapidly dividing cells. Chemotherapy is highly recommended if the underlying breast cancer is large, has an aggressive growth rate (high grade), or if malignant cells are found inside the underarm lymph nodes.

Endocrine (Hormone) Therapy: The pathologist will test the tumor cells to see if they express specific hormone receptors on their surface. If the cancer tests positive for estrogen receptors (ER+) or progesterone receptors (PR+), it means the body’s natural hormones are fueling the cancer’s growth. To block these pathways, doctors prescribe daily oral medications, such as tamoxifen for premenopausal women or aromatase inhibitors (like anastrozole or letrozole) for postmenopausal women, typically for a period of 5 to 10 years to reduce the risk of a future recurrence.

Targeted Biological Therapy: A significant percentage of underlying breast cancers associated with Paget’s disease overexpress the Human Epidermal Growth Factor Receptor 2 (HER2) protein. HER2-positive tumors tend to grow and multiply more quickly. To target this specific pathway, oncologists introduce specialized monoclonal antibodies, such as trastuzumab and pertuzumab. These biological medications act as targeted treatments, binding directly to the HER2 receptors on the cancer cells to shut down their growth signals and mark them for destruction by the body’s immune system, while sparing healthy cells.

Conclusion

Paget’s disease of the breast can be difficult to recognize because it often begins with symptoms that resemble eczema, dry skin, or irritation. Flaking, itching, redness, crusting, burning, discharge, or nipple changes should not be ignored when they are persistent, one-sided, or do not improve with basic skin care. While many nipple rashes are not cancer, only a healthcare professional can determine the true cause through examination and testing. If you notice ongoing changes around the nipple or areola, especially on one breast, scheduling a medical evaluation is a careful and proactive step.

Read more: 10 Symptoms of Atrophic Gastritis You Should Know

Frequently Asked Questions

1. What is Paget’s disease of the breast?

Paget’s disease of the breast is a rare type of breast cancer that mainly affects the nipple and often the areola. It can cause skin changes that look similar to eczema, dermatitis, or a persistent rash. Many cases are associated with an underlying breast cancer, such as ductal carcinoma in situ or invasive breast cancer. Because the symptoms can appear mild at first, medical evaluation is important when nipple changes do not go away.

2. Why is Paget’s disease of the breast often mistaken for a skin condition?

Paget’s disease of the breast can cause redness, itching, flaking, scaling, crusting, and irritation around the nipple. These symptoms can look very similar to common skin problems, especially eczema or contact dermatitis. The difference is that Paget-related symptoms often persist, worsen, or affect only one nipple. A rash that does not improve with usual care should be checked by a healthcare provider.

3. What symptoms should raise concern?

Symptoms that may raise concern include flaky skin on the nipple, crusting, oozing, burning, itching, nipple discharge, or a flattened nipple. Some people may also feel a lump or notice thickened skin in the breast. Bloody or yellowish discharge should be evaluated, especially if it happens without squeezing the nipple. Any one-sided nipple or areola change that continues over time deserves medical attention.

4. How is Paget’s disease of the breast diagnosed?

Diagnosis usually begins with a breast exam and a review of nipple or skin changes. A doctor may recommend imaging tests such as a mammogram, ultrasound, or MRI to look for cancer inside the breast. A biopsy is often needed to examine tissue under a microscope and confirm the diagnosis. These steps help separate Paget’s disease of the breast from noncancerous skin conditions.

5. Is Paget’s disease of the breast treatable?

Yes, Paget’s disease of the breast is treatable, but treatment depends on whether there is underlying breast cancer and how advanced it is. Options may include surgery, radiation therapy, chemotherapy, hormone therapy, or targeted therapy. The treatment plan is personalized based on test results, tumor features, and the patient’s overall health. Early diagnosis can improve the chance of receiving effective treatment before the disease progresses.

Sources

• Paget’s Disease of the Breast – Symptoms & Causes (Mayo Clinic)
• Paget Disease of the Breast (National Cancer Institute)
• Paget’s Disease of the Breast: Symptoms, Diagnosis & Treatment (Cleveland Clinic)
• Paget Disease of the Breast (American Cancer Society)
• Mammary Paget Disease – StatPearls (NCBI Bookshelf)
• Paget’s Disease of the Breast – Diagnosis & Treatment (Mayo Clinic)